CB04.7

ICD-11 MMS 2026-01

Neuroendocrine cell hyperplasia of infancy

Description

Neuroendocrine cell hyperplasia of infancy is a non-lethal paediatric form of interstitial lung disease (ILD) characterised by tachypnoea and respiratory distress without respiratory failure.

Index terms

  • Neuroendocrine cell hyperplasia of infancy
  • NCHI - [Neuroendocrine cell hyperplasia of infancy]
  • NEHI - [Neuroendocrine cell hyperplasia of infancy]
Show allHide
  • Persistent tachypnoea of infancy

Exclusions from above levels

  • 01 – Certain infectious or parasitic diseases
  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth and the puerperium
Show allHide
  • 19 – Certain conditions originating in the perinatal period
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • CB04.0 – Diffuse pulmonary developmental disorders
  • CB04.1 – Pulmonary lymphatic dysplasia syndromes
  • CB04.2 – Disorders of surfactant metabolism
  • CB04.3 – Alveolar or peri-alveolar conditions
  • CB04.4 – Pulmonary capillaritis
  • CB04.5 – Brain-lung-thyroid syndrome
  • CB04.6 – Chronic pneumonitis of infancy
  • CB04.Y – Other specified primary interstitial lung diseases specific to infancy or childhood
  • CB04.Z – Primary interstitial lung diseases specific to infancy or childhood, unspecified

Foundation entity

Neuroendocrine cell hyperplasia of infancy – http://id.who.int/icd/entity/1641999159

Allowed postcoordination axes

Part of: CB04: Primary interstitial lung diseases specific to infancy or childhood › 12: Diseases of the respiratory system